RS 09

• UNSPSC Description:

  RS09 is a LPS peptide mimic serves as a candidate to be considered as a new class of TLR4 agonist adjuvant. RS09 increases antibody production in a vaccine setting[1].

• Target Antigen:

  Toll-like Receptor (TLR)

• Type:

  Peptides

• Related Pathways:

  Immunology/Inflammation

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/rs-09.html

• Purity:

  99.83

• Solubility:

  H2O : 100 mg/mL (ultrasonic)

• Smiles:

  OC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H]1CCCN1C([C@@H]2CCCN2C([C@@H](N)C)=O)=O)=O)CC3=CNC=N3)=O)C)=O)CC(C)C)=O)CO)=O

• Molecular Weight:

  691.78

• References & Citations:

  [1]Shanmugam A, et al. Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants. PLoS One. 2012;7(2):e30839.Bioact Mater. 2022 Nov 9;23:69-79.|Bioact Mater. 2023, 23: 69-79.|Int Immunopharmacol. 2024 May 9:134:112188.|Phytomedicine. 28 July 2022, 154360.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Clinical Information:

  No Development Reported

• CAS Number:

  1449566-36-2